1. Home
  2. FOLD vs DOOO Comparison

FOLD vs DOOO Comparison

Compare FOLD & DOOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • DOOO
  • Stock Information
  • Founded
  • FOLD 2002
  • DOOO 1937
  • Country
  • FOLD United States
  • DOOO Canada
  • Employees
  • FOLD N/A
  • DOOO N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • DOOO
  • Sector
  • FOLD Health Care
  • DOOO
  • Exchange
  • FOLD Nasdaq
  • DOOO Nasdaq
  • Market Cap
  • FOLD 2.9B
  • DOOO 2.7B
  • IPO Year
  • FOLD 2007
  • DOOO N/A
  • Fundamental
  • Price
  • FOLD $6.12
  • DOOO $50.02
  • Analyst Decision
  • FOLD Buy
  • DOOO Buy
  • Analyst Count
  • FOLD 10
  • DOOO 5
  • Target Price
  • FOLD $16.22
  • DOOO $43.00
  • AVG Volume (30 Days)
  • FOLD 5.5M
  • DOOO 318.9K
  • Earning Date
  • FOLD 08-07-2025
  • DOOO 09-05-2025
  • Dividend Yield
  • FOLD N/A
  • DOOO 1.22%
  • EPS Growth
  • FOLD N/A
  • DOOO N/A
  • EPS
  • FOLD N/A
  • DOOO N/A
  • Revenue
  • FOLD $543,141,000.00
  • DOOO $5,555,499,267.00
  • Revenue This Year
  • FOLD $19.87
  • DOOO N/A
  • Revenue Next Year
  • FOLD $23.15
  • DOOO $5.67
  • P/E Ratio
  • FOLD N/A
  • DOOO N/A
  • Revenue Growth
  • FOLD 28.25
  • DOOO N/A
  • 52 Week Low
  • FOLD $5.51
  • DOOO $31.78
  • 52 Week High
  • FOLD $12.65
  • DOOO $74.00
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 51.42
  • DOOO 60.01
  • Support Level
  • FOLD $5.66
  • DOOO $50.45
  • Resistance Level
  • FOLD $6.45
  • DOOO $52.06
  • Average True Range (ATR)
  • FOLD 0.21
  • DOOO 1.58
  • MACD
  • FOLD 0.07
  • DOOO -0.26
  • Stochastic Oscillator
  • FOLD 64.89
  • DOOO 58.49

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About DOOO BRP Inc. (Recreational Products) Common Subordinate Voting Shares

BRP designs, develops, manufactures, distributes, and markets snowmobiles, all-terrain vehicles, and personal watercraft under the Ski-Doo, Sea-Doo, Can-Am, and Lynx brand names. It also builds engines under the Rotax brand (after shuttering the Evinrude outboard engine business in 2020) and offers clothing, parts, and accessories that cater to its core consumers. In 2018, BRP created a marine group, which is now being unwound (Manitou pontoon boats remain up for sale). At the end of fiscal 2025, the company sold its products through a network of more than 2,400 independent dealers and 140 distributors in around 130 countries.

Share on Social Networks: